���ϳԹ���

An international team of researchers led by a ���ϳԹ��� School of Medicine scientist has uncovered a novel mechanism in which a protein—neuregulin 3—controls how key neurotransmitters are released in the brain during schizophrenia. The protein is elevated in people with schizop...

As the result of a six-year long research process, Fredrick R. Schumacher, PhD, MPH, a cancer epidemiology researcher at ���ϳԹ��� School of Medicine, and an international team of more than 100 colleagues have identified 63 new genetic variations that could indicate higher risk...

WATCH VIDEO Researchers from ���ϳԹ��� School of Medicine and colleagues have discovered how two brain regions work together to maintain attention, and how discordance between the regions could lead to attention deficit disorders, including schizophrenia, bipolar disorder, and...

Leading cancer researchers, Alex Huang MD, PhD, and Yamilet Huerta, MD have been awarded $186,405 in grants from the St. Baldrick’s Foundation to conduct pediatric cancer research. Huang, professor of pediatrics at ���ϳԹ��� School of Medicine and co-leader of the Hematopoieti...

Ahmad Khalil, PhD Certain genes that code for proteins have long been known to contribute to cancer progression. But in a frame shift, researchers from ���ϳԹ��� School of Medicine recently found that non-coding genes also contribute to the development and spreading ...

"Our goal is to uncover more about the mechanism of Alzheimer’s and other diseases that involve memory loss and the breakdown of the neurological system." - Rong Xu, PhD Sports concussions, Parkinson’s disease, and hormone therapy for cancer – all can have memory loss as symptoms. B...

human Estrogen Receptor alpha Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually develop drug resistance, leaving doctors desperate for alterna...

Researchers from ���ϳԹ��� School of Medicine have shown that a single “cocktail” of three pill-based anti-parasite medications is significantly more effective at killing microscopic larval worms in people diagnosed with lymphatic filariasis, commonly known as elephantiasis, th...

Alex Huang, MD, PhD Leading cancer researcher, Alex Huang MD, PhD, has been awarded a three-year, $1.35 million grant from the St. Baldrick’s Foundation and the Osteosarcoma Collaborative to develop new ways to treat osteosarcoma, a rare cancer that begins in the bone. Huang, who is a pr...

Mukesh Jain, MD, and colleagues have been awarded a five-year, $6M grant from the Paris-based Fondation Leducq to conduct a thorough analysis of the pivotal role of KLF2 in vascular-related functions and disorders. The team’s grant was one of five awarded globally and aims to improve knowledge and t...